Moderna
Patents, profits and squabbles for share in the pie – Moderna’s pandemic story

Moderna’s filing for patents in South Africa puts a question mark on its intentions of honoring the pledge that it will not enforce patents during the pandemic. Activists fear that this may jeopardize the WHO’s technology sharing hub

Not Omicron but greed of capital threatens the world

The deliberate policy of big pharma and rich countries to leave large populations in poorer countries unvaccinated could plunge the world into another downturn

241 million vaccine doses to go to waste if not redistributed immediately

G7 countries will have 1.2 billion vaccines available for donation by the end of 2021 even after maintaining booster shot campaigns for all adults

Can poor countries succeed in vaccinating their population?

Public outcry in South Africa helped force Johnson & Johnson to retain the vaccines produced in the country for domestic use instead of being shipped to Europe. The Indian civil society has initiated a similar effort as the Global South looks for alternatives

Big pharma — Maximum earnings, minimum responsibilities

The COVID-19 pandemic has again exposed the true nature of capitalism with profit being the primary driver irrespective of the rising inequalities

G-7 offers crumbs from its table to ‘developing’ countries

As of now, the total unvaccinated population in the world numbers 6.8 billion. The one billion doses promised by the G-7 countries can meet the needs of only 7.4% of this number

Cuba’s COVID-19 vaccines: A journey of collaboration and revolutionary solidarity

With its development of five COVID-19 vaccines and the promise of sharing know-how with developing countries, Cuba has remained faithful to Che Guevara’s values of international solidarity and people-oriented medicine

Vaccine apartheid in Palestine: The silent war by Israel

In violation of its obligations and responsibilities as an occupying power, Israel has taken little effort in vaccinating Palestinians, leading to very poor vaccination rates in the occupied territories and the general deterioration of health facilities

Neutralising antibodies can be marker of COVID-19 vaccine efficacy

A new research shows that even a small quantity of the neutralising antibodies indicates a strong efficacy of the vaccine

COVID-19 vaccine: Who holds intellectual property rights?

Immunologist Dr. Satyajit Rath and Newsclick’s Prabir Purkayastha talk about the recent debates on the intellectual property rights on vaccines and the possibilities of mass immunization

Why do we need global vaccination?

Newsclick’s Prabir Purkayastha and immunologist Dr. Satyajit Rath discuss the politics, economics and technical aspects of the global vaccine scenario in light of Bill Gates’ recent statement on technology transfer

How pharma companies created a bottleneck in vaccine distribution

Private pharma companies and developed nations have created a bottleneck in vaccine distribution through the use of patents and legislation

    × To Subscribe